Sign In
Get Clay Free →

Suggestions

    Keith Murphy

    CEO and Founder, Viscient Biosciences • Founder & Executive Chairman, Organovo • Entrepreneur and Investor

    Keith Murphy is a prominent figure in the biotechnology industry, known for his role as the former CEO and Founder of Viscient Biosciences, a company focused on developing drugs utilizing human 3D bioprinted tissues.

    His expertise lies in leveraging innovative technologies such as Organovo ExVive Liver technology to discover and develop novel compounds, revolutionizing traditional drug discovery processes.

    With a strong educational background from institutions like UCLA Anderson School of Management and Massachusetts Institute of Technology, Keith Murphy brings a wealth of knowledge and experience to the table.

    Prior to his involvement with Viscient Biosciences, he held various leadership positions at prominent organizations like Organovo Holdings, Inc., Amgen, Inc., and Alkermes, Inc., showcasing his diverse skill set and versatility in the biotech sector.

    Keith Murphy
    Add to my network

    Location

    Los Angeles Metropolitan Area